December 4, 2018

Why Regulatory Due Diligence is Essential in Healthcare PE Transactions

The PE Hub Network
Jeffrey W. Mittleman | Jenna F. Schapiro

Partner Jeffrey Mittleman and Associate Jenna Schapiro co-authored an article for The PE Hub Network on "Why Regulatory Due Diligence is Essential in Healthcare PE Transactions" in which they discuss the risks that a private equity buyer could be liable for if due diligence is not properly done especially if the buyer is new to the healthcare market. One such liability would be in making sure that the healthcare practice is never without a license (as state licensure requirements often include a change of ownership provision). Mr. Mittleman and Ms. Schapiro reviewed that such a violation could be severe and can result in steep fines, criminal charges and license revocation.

READ: Why Regulatory Due Diligence is Essential in Healthcare PE Transactions (Subscription Required)

Related Insights